Literature DB >> 16448746

Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.

Katrin Arnold1, Min-Kyoung Kim, Katrin Frerk, Lutz Edler, Larissa Savelyeva, Peter Schmezer, Ruprecht Wiedemeyer.   

Abstract

The BRCA2 protein is involved in the maintenance of genomic stability through its key role in homologous recombination repair of DNA double strand breaks. Biallelic inactivation of BRCA2 leads to a defect in DNA repair and is associated with a chromosomal instability phenotype. Recent studies on familial breast cancer clusters revealed chromosomal rearrangements and higher rates of sister chromatid exchanges also in heterozygous BRCA2 mutation carriers. In the present study, lymphoblastoid cell lines of heterozygous BRCA2 mutation carriers and of wildtype relatives were compared with regard to BRCA2 mRNA and protein expression and capacity to repair DNA damage induced by gamma-irradiation and mitomycin C. BRCA2+/- cells showed lower amounts of the full-length BRCA2 protein compared to BRCA2+/+ cells. The kinetics of gamma-H2AX protein level revealed distinct defects in DNA double strand break repair in the BRCA2+/- cells. These results are indicative of a haploinsufficiency phenotype in BRCA2+/- cells, suggesting that reduced amounts of functional BRCA2 protein in BRCA2+/- carriers are insufficient for an efficient repair of DNA double strand breaks, a condition that could contribute to the impairment of genomic stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448746     DOI: 10.1016/j.canlet.2005.11.041

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.

Authors:  Logan C Walker; Bryony A Thompson; Nic Waddell; Sean M Grimmond; Amanda B Spurdle
Journal:  PLoS Genet       Date:  2010-02-19       Impact factor: 5.917

2.  Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations.

Authors:  Jeffrey T Holt; William P Toole; Vedang R Patel; HeeYoung Hwang; Erika T Brown
Journal:  Cancer Genet Cytogenet       Date:  2008-10-15

3.  Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.

Authors:  Ana-Teresa Maia; Antonis C Antoniou; Martin O'Reilly; Shamith Samarajiwa; Mark Dunning; Christiana Kartsonaki; Suet-Feung Chin; Christina N Curtis; Lesley McGuffog; Susan M Domchek; Douglas F Easton; Susan Peock; Debra Frost; D Gareth Evans; Ros Eeles; Louise Izatt; Julian Adlard; Diana Eccles; Olga M Sinilnikova; Sylvie Mazoyer; Dominique Stoppa-Lyonnet; Marion Gauthier-Villars; Laurence Faivre; Laurence Venat-Bouvet; Capucine Delnatte; Heli Nevanlinna; Fergus J Couch; Andrew K Godwin; Maria Adelaide Caligo; Rosa B Barkardottir; Xiaoqing Chen; Jonathan Beesley; Sue Healey; Carlos Caldas; Georgia Chenevix-Trench; Bruce A J Ponder
Journal:  Breast Cancer Res       Date:  2012-04-18       Impact factor: 6.466

4.  Reduced canine BRCA2 expression levels in mammary gland tumors.

Authors:  Yasunaga Yoshikawa; Masami Morimatsu; Kazuhiko Ochiai; Toshina Ishiguro-Oonuma; Seiichi Wada; Koichi Orino; Kiyotaka Watanabe
Journal:  BMC Vet Res       Date:  2015-07-23       Impact factor: 2.741

5.  Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.

Authors:  Annelot Baert; Julie Depuydt; Tom Van Maerken; Bruce Poppe; Fransiska Malfait; Tim Van Damme; Sylvia De Nobele; Gianpaolo Perletti; Kim De Leeneer; Kathleen B M Claes; Anne Vral
Journal:  Oncol Rep       Date:  2017-01-25       Impact factor: 3.906

6.  Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.

Authors:  Gabriel S Macedo; Barbara Alemar; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2019-04-29       Impact factor: 1.771

Review 7.  Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.

Authors:  Pauline Thumser-Henner; Katarzyna J Nytko; Carla Rohrer Bley
Journal:  BMC Vet Res       Date:  2020-01-31       Impact factor: 2.741

8.  Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.

Authors:  Sailesh Gochhait; Syed Irfan Ahmad Bukhari; Narendra Bairwa; Shivani Vadhera; Katayoon Darvishi; Mohammad Raish; Pawan Gupta; Syed Akhtar Husain; Rameshwar N K Bamezai
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  DNA damage repair is unaffected by mimicked heterozygous levels of BRCA2 in HT-29 cells.

Authors:  Brian Tannenbaum; Tobechukwu Mofunanya; Alan R Schoenfeld
Journal:  Int J Biol Sci       Date:  2007-09-30       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.